VR Logo

Medicinova Inc (MNOV) download report


Healthcare | Biotechnology & Pharma Research

Medicinova Inc (MNOV) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States.

IPO Date: 08-Feb-2005

Co-Founder, Pres, CEO & Exec. Director: Dr. Yuichi Iwaki M.D., Ph.D.

Chief Medical Officer & Director: Dr. Kazuko Matsuda M.D., M.P.H., MPH, Ph.D.

Listing: NASDAQ: MNOV

Country: United States

Headquarters: La Jolla, CA

Website: https://www.medicinova.com

Key Facts

Market cap: $121.14 Mln

Revenue (TTM): $1.82 Mln

Earnings (TTM): $-13.33 Mln

Cash: $67.70 Mln

Total Debt: $0.16 Mln

Insider's Holding: 3.01%

Liquidity: Low

52 Week range: $2.09 - 4.65

Shares outstanding: 49,046,200

10 Years Aggregate:

  • CFO: $-80.76 Mln
  • EBITDA: $-110.48 Mln
  • Net Profit: $-106.66 Mln

Stock Performance

Time Period Medicinova (MNOV) S&P BSE Sensex S&P Small-Cap 600
YTD-7.84-9.18-18.78
1 month-0.80-4.78-8.00
3 months-7.49-9.66-13.65
1 Year-41.880.81-17.19
3 Years-36.4610.336.10
5 Years-14.0311.345.87
10 Years4.2411.749.84
As on 01-Jul-2022
Year Medicinova (MNOV) S&P Small-Cap 600 S&P BSE Sensex
2021-49.0525.2721.99
2020-21.969.5715.75
2019-17.5020.8614.38
201826.11-9.705.87
20177.3011.7327.91
201669.8624.741.95
201516.78-3.36-5.03